Probiotic Trial Outcomes for Functional Constipation in Adults

78 adults with functional constipation participated in a randomized, double-blind, placebo-controlled trial over 4 weeks. The dataset contains outcomes measuring changes in bowel movements, stool form, and physical functioning scores. Hyung Gyu Park published the data on figshare in April 2026.

Use Cases

• Analyzing the efficacy of a specific probiotic blend based on changes in weekly spontaneous bowel movements.
• Evaluating stool consistency shifts based on Bristol stool type classifications.
• Comparing physical well-being improvements between treatment and placebo groups based on SF-36 survey scores.
• Investigating symptom alleviation for functional constipation based on metrics for incomplete evacuation and abdominal pain.

Strengths

• Data originates from a randomized, double-blind, placebo-controlled trial, a rigorous study design.
• 78 participant records are included, split between a probiotic blend group (n=40) and a placebo group (n=38).
• Primary and secondary outcomes are clearly defined, including specific p-values for significant results.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is 40.9 KB, indicating a very limited scope of data.

Provenance

Source

figshare

Collection Method

Data collected from a clinical trial registered with the Clinical Research Information Service (CRIS), KCT0010085.

Time Range

Trial duration was 4 weeks.

Freshness

Last updated 2026-04-24 17:43:12; freshness should be verified.